CN111777629B - Dithiobis-mannobiose-gold nanoprobe, preparation method and application - Google Patents
Dithiobis-mannobiose-gold nanoprobe, preparation method and application Download PDFInfo
- Publication number
- CN111777629B CN111777629B CN202010787460.9A CN202010787460A CN111777629B CN 111777629 B CN111777629 B CN 111777629B CN 202010787460 A CN202010787460 A CN 202010787460A CN 111777629 B CN111777629 B CN 111777629B
- Authority
- CN
- China
- Prior art keywords
- mannobiose
- bis
- ligand
- gold
- sulfur
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229910052737 gold Inorganic materials 0.000 title claims abstract description 31
- 239000010931 gold Substances 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- 239000003446 ligand Substances 0.000 claims abstract description 32
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000011593 sulfur Substances 0.000 claims abstract description 13
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 13
- GUBGYTABKSRVRQ-PZPXDAEZSA-N 4β-mannobiose Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-PZPXDAEZSA-N 0.000 claims abstract description 11
- DKXNBNKWCZZMJT-UHFFFAOYSA-N O4-alpha-D-Mannopyranosyl-D-mannose Natural products O=CC(O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O DKXNBNKWCZZMJT-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000002105 nanoparticle Substances 0.000 claims abstract description 11
- 238000000034 method Methods 0.000 claims abstract description 8
- 108010066342 Virus Receptors Proteins 0.000 claims abstract description 5
- 102000018265 Virus Receptors Human genes 0.000 claims abstract description 5
- 239000000523 sample Substances 0.000 claims abstract description 3
- 108010037897 DC-specific ICAM-3 grabbing nonintegrin Proteins 0.000 claims abstract 3
- 238000003756 stirring Methods 0.000 claims description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- 238000004440 column chromatography Methods 0.000 claims description 11
- CQXDYHPBXDZWBA-UHFFFAOYSA-N tert-butyl 2,2,2-trichloroethanimidate Chemical compound CC(C)(C)OC(=N)C(Cl)(Cl)Cl CQXDYHPBXDZWBA-UHFFFAOYSA-N 0.000 claims description 7
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 5
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 claims description 5
- 235000010378 sodium ascorbate Nutrition 0.000 claims description 5
- 229960005055 sodium ascorbate Drugs 0.000 claims description 5
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- PZBFGYYEXUXCOF-UHFFFAOYSA-N TCEP Chemical compound OC(=O)CCP(CCC(O)=O)CCC(O)=O PZBFGYYEXUXCOF-UHFFFAOYSA-N 0.000 claims description 4
- JZCCFEFSEZPSOG-UHFFFAOYSA-L copper(II) sulfate pentahydrate Chemical compound O.O.O.O.O.[Cu+2].[O-]S([O-])(=O)=O JZCCFEFSEZPSOG-UHFFFAOYSA-L 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 3
- 239000003153 chemical reaction reagent Substances 0.000 claims description 2
- 238000001514 detection method Methods 0.000 claims description 2
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 2
- 239000012498 ultrapure water Substances 0.000 claims description 2
- 102100040843 C-type lectin domain family 4 member M Human genes 0.000 abstract description 6
- 101000749311 Homo sapiens C-type lectin domain family 4 member M Proteins 0.000 abstract description 6
- 238000010791 quenching Methods 0.000 abstract description 6
- 230000000171 quenching effect Effects 0.000 abstract description 6
- 235000000346 sugar Nutrition 0.000 abstract description 5
- 230000003993 interaction Effects 0.000 abstract description 3
- 230000008275 binding mechanism Effects 0.000 abstract description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- 150000001875 compounds Chemical class 0.000 description 15
- 230000015572 biosynthetic process Effects 0.000 description 14
- 238000003786 synthesis reaction Methods 0.000 description 14
- 239000000243 solution Substances 0.000 description 11
- -1 bis-mannose bis-gold Chemical compound 0.000 description 9
- 238000001816 cooling Methods 0.000 description 9
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 8
- 238000001035 drying Methods 0.000 description 7
- 238000004896 high resolution mass spectrometry Methods 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 238000002390 rotary evaporation Methods 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 235000003704 aspartic acid Nutrition 0.000 description 4
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 238000004949 mass spectrometry Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 3
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 3
- 108090000288 Glycoproteins Proteins 0.000 description 3
- 102000003886 Glycoproteins Human genes 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- DRUIESSIVFYOMK-UHFFFAOYSA-N Trichloroacetonitrile Chemical compound ClC(Cl)(Cl)C#N DRUIESSIVFYOMK-UHFFFAOYSA-N 0.000 description 3
- YFHNDHXQDJQEEE-UHFFFAOYSA-N acetic acid;hydrazine Chemical compound NN.CC(O)=O YFHNDHXQDJQEEE-UHFFFAOYSA-N 0.000 description 3
- 238000002189 fluorescence spectrum Methods 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108090000342 C-Type Lectins Proteins 0.000 description 2
- 102000003930 C-Type Lectins Human genes 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- PHSPJQZRQAJPPF-UHFFFAOYSA-N N-alpha-Methylhistamine Chemical compound CNCCC1=CN=CN1 PHSPJQZRQAJPPF-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000002296 dynamic light scattering Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 239000002523 lectin Substances 0.000 description 2
- 239000002808 molecular sieve Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N sodium azide Substances [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- XXFUZSHTIOFGNV-UHFFFAOYSA-N 1-bromoprop-1-yne Chemical compound CC#CBr XXFUZSHTIOFGNV-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- GIAFURWZWWWBQT-UHFFFAOYSA-N 2-(2-aminoethoxy)ethanol Chemical compound NCCOCCO GIAFURWZWWWBQT-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
- 101710186708 Agglutinin Proteins 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241001115402 Ebolavirus Species 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 101710146024 Horcolin Proteins 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 101710189395 Lectin Proteins 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 101710179758 Mannose-specific lectin Proteins 0.000 description 1
- 101710150763 Mannose-specific lectin 1 Proteins 0.000 description 1
- 101710150745 Mannose-specific lectin 2 Proteins 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000000333 X-ray scattering Methods 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 239000000910 agglutinin Substances 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229910052927 chalcanthite Inorganic materials 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 210000004443 dendritic cell Anatomy 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000015788 innate immune response Effects 0.000 description 1
- 102000006495 integrins Human genes 0.000 description 1
- 108010044426 integrins Proteins 0.000 description 1
- 230000005732 intercellular adhesion Effects 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical group 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000002096 quantum dot Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- DPKBAXPHAYBPRL-UHFFFAOYSA-M tetrabutylazanium;iodide Chemical compound [I-].CCCC[N+](CCCC)(CCCC)CCCC DPKBAXPHAYBPRL-UHFFFAOYSA-M 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000002424 x-ray crystallography Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
- C07F1/12—Gold compounds
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/02—Use of particular materials as binders, particle coatings or suspension media therefor
- C09K11/025—Use of particular materials as binders, particle coatings or suspension media therefor non-luminescent particle coatings or suspension media
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/18—Metal complexes
- C09K2211/188—Metal complexes of other metals not provided for in one of the previous groups
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6432—Quenching
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
Abstract
The invention belongs to the field of glycochemistry and biology, and particularly relates to a dithiobis-mannobiose-gold nanoprobe, a preparation method and application thereof in virus receptor DC-SIGN/R recognition. A double-sulfur double-mannose-gold nano probe is characterized in that: modifying the surface of the gold nanoparticles with a dithiobis-mannobiose ligand by a ligand exchange method. According to the invention, based on click chemistry and ligand exchange, a mannobiose ligand is modified on the surface of a gold nanoparticle, a novel dithiobis-mannobiose-gold nanoprobe is constructed, and based on a fluorescence quenching strategy, the sugar binding mechanisms of tetramer lectins DC-SIGN and DC-SIGNR are researched, so that a foundation is laid for establishing a rapid and sensitive method and researching the binding affinity and thermodynamics between protein-sugar multivalent interactions.
Description
Technical Field
The invention belongs to the field of glycochemistry and biology, and particularly relates to a dithiobis-mannobiose-gold nanoprobe, a preparation method and application thereof in virus receptor DC-SIGN/R recognition.
Technical Field
C-type lectins are a class containing calcium ions (Ca)2+) The carbohydrate recognition domain-dependent (CRDs) superfamily of proteins, which bind to the surface sugars of various viral glycoproteins, play a key role in many important biological processes, such as innate immunity and serum glycoprotein clearance (Biochemistry,2004,43, 3783-. In 2001, Feinberg topic group (Science,2001,294,2163-2166) reported in Science that two important type II membrane proteins consisting of C-type lectin receptors, DC-SIGN (dendritic Cell surface-specific intercellular adhesion factor-3-binding non-integrin factor) and DC-SIGNR (endothelial Cell receptor closely related to DC-SIGN), were bound to oligosaccharide in the CRD crystal structure (Cell,2000,100,587)-597). The two have high affinity to sugar-containing molecules, especially mannose, such as mannose existing on the surface of HIV and Ebola virus glycoprotein, and viral infection can be promoted by combining hydroxyl on a mannose pyran ring with CRD of protein.
DC-SIGN and DC-SIGNR are closely related to the occurrence of body infectious diseases as important recognition receptors of pathogenic microorganisms such as viruses and bacteria. Despite the extensive research performed by scientists over the past 20 years, the detailed protein structure remains unknown except for structural models based on solution X-ray scattering data (without X-ray crystallography validation).
The gold nanoparticles not only have size-dependent and adjustable fluorescence spectrum, high quantum efficiency and large Stokes shift, but also have the advantages of small particle size, no toxicity, good biocompatibility and the like which are not possessed by fluorescent dyes, quantum dots and the like, so that the gold nanoparticles become an ideal fluorescent probe.
The invention aims to prepare a dithiobis-mannobiose-gold nanoprobe, discusses the interaction with tetramer agglutinin DC-SIGN and DC-SIGNR, and lays a foundation for developing specific multivalent inhibition blocking DC-SIGN/R mediated virus infection.
Disclosure of Invention
The invention aims to provide a dithiobis-mannobiose-gold nanoprobe, a preparation method and application thereof in virus receptor DC-SIGN/R recognition.
A double-sulfur double-mannose-gold nano probe is characterized in that: modifying the surface of the gold nanoparticles with a dithiobis-mannobiose ligand by adopting a ligand exchange method, wherein the structure is shown as a formula I:
x is 1 to 1500.
The object of the invention can be achieved by the following measures:
the bis-mannose bis-gold nanoprobe (i.e., the substance of formula I) was prepared as follows: dissolving 1 mol of gold nanoparticles, 1-2000 mol of bis-sulfur bis-mannobiose ligand II and 1-2500 mol of tris (2-carboxyethyl) phosphine (TCEP) in ultrapure water, stirring at room temperature in a dark place for 12-24 h, concentrating, washing with water, and preparing a bis-sulfur bis-mannobiose-gold nanoprobe I, wherein the process comprises the following steps:
the disulfide bis-mannobiose ligand shown in the general formula II is prepared from mannobiose ligand III, disulfide ligand IV, tert-butyl trichloroacetimidate (TBTA), copper sulfate pentahydrate and sodium ascorbate through click chemistry. Wherein the molar ratio of the disulfide ligand IV to the mannobiose ligand III to the tert-butyl trichloroacetimidate (TBTA) to the copper sulfate pentahydrate to the sodium ascorbate is 1: 2-3: 0.1-0.3: 0.05-0.2: 0.1-1, and stirring the mixture at room temperature in a dark place by using a solvent methanol or ethanol, wherein the product is separated and purified by column chromatography. The specific reaction formula is as follows:
according to the synthesis references of mannobiose ligands shown in the general formula III J.Am.chem.Soc.2017,139,11833-11844, mannose and peracetyl mannose are used as raw materials and react with acetic anhydride, phosphorus tribromide, hydrazine acetate, trichloroacetonitrile and DBU respectively to prepare III-4 and III-5. Then reacting with boron trifluoride ethyl ether solution at low temperature to prepare III-3. Reference is made to the synthesis of III-5 for preparation of III-2. III-2 is sequentially reacted with H (OCH)2CH2)3Cl and NaN3And reacting to prepare III-1. Finally, III-1 is hydrolyzed under alkaline condition to prepare the mannobiose III, and the specific reaction formula is as follows:
the disulfide ligand IV is prepared by taking aspartic acid as a raw material, sequentially reacting with di-tert-butyl dicarbonate and alkynylamine IV-1 to prepare Boc-protected alkynylamine IV-3, then deprotecting, and condensing with lipoic acid through DCC, and the specific reaction formula is as follows:
the application of the bis-sulfur bis-mannobiose-gold nanoprobe in preparing a virus receptor DC-SIGN/R detection reagent.
Advantageous effects
According to the invention, based on click chemistry and ligand exchange, a mannobiose ligand is modified on the surface of a gold nanoparticle, a novel dithiobis-mannobiose-gold nanoprobe is constructed, and based on a fluorescence quenching strategy, the sugar binding mechanisms of tetramer lectins DC-SIGN and DC-SIGNR are researched, so that a foundation is laid for establishing a rapid and sensitive method and researching the binding affinity and thermodynamics between protein-sugar multivalent interactions.
Drawings
FIG. 1 shows a high resolution mass spectrum of a bis-sulfur bis-mannobiose ligand II (n-2).
FIG. 2 shows the UV-VIS absorption spectrum of the bis-mannose-gold nanoprobe I.
FIG. 3 is a dynamic light scattering characterization of the bis-mannose-gold nanoprobe I.
FIG. 4 is a graph showing the binding of the bis-mannose-gold nanoprobe I to DC-SIGN.
FIG. 5 is a graph showing the binding of the bis-mannobiose gold nanoprobe I to DC-SIGNR.
Detailed Description
The following specific examples are provided to further illustrate the invention.
The starting gold nanoparticles (5 nm in diameter, dispersed in PBS solution) were purchased from Sigma-Aldrich.
Synthetic examples
Example 1
Synthesis of Compound III-4
Dissolving mannose in acetic anhydride, adding a few drops of perchloric acid, stirring at room temperature for 1 hour, cooling to 10 ℃, dropwise adding phosphorus tribromide, and controlling the temperature to be 20-25 ℃. After the completion of the dropping, the mixture was stirred at room temperature for 1.5 hours. Cooling to 5 deg.C, adding sodium acetate solution, controlling temperature at 20-25 deg.C, and stirring for 20 min. Chloroform extraction, saturated sodium bicarbonate solution and water washing, drying with anhydrous sodium sulfate, filtration and concentration. Recrystallization from cold ether afforded compound III-4 as a white solid at m.p.132-133 ℃. High resolution mass spectrometry data: [ M + NH ]4]+366.1395 (theoretical), 366.1400 (measured).
Example 2
Synthesis of Compound III-5
Under the protection of nitrogen, dissolving the total acetyl alpha-D-mannose in DMF, heating to 50 ℃, adding hydrazine acetate, stirring for 20 minutes, cooling, adding ethyl acetate, washing with saturated saline solution, drying with anhydrous sodium sulfate, filtering and concentrating. Dichloromethane was added, cooled to-10 ℃, trichloroacetonitrile and Diazabicyclo (DBU) were added dropwise, and the mixture was allowed to warm to room temperature and stirred for 2 hours. Concentrating, separating by column chromatography to obtain compound III-5 as colorless liquid. High resolution mass spectrometry data: [2M + Na ]]+1005.0198 (theoretical), 1005.0175 (measured).
Example 3
Synthesis of Compound III-3
The compounds III-4 and III-5 were co-distilled with toluene, followed by addition of anhydrous dichloromethane and 4A type molecular sieve, and stirring at room temperature for 2 hours. Cooling to-50 deg.C, adding boron trifluoride ether solution, slowly heating to room temperature, and reacting for 18 hr. Adding sodium bicarbonate, filtering, concentrating, separating by column chromatography, and making into desired dosage formCompound III-3, white solid, m.p.70-71 ℃. High resolution mass spectrometry data: [ M + Na ]]+701.1900 (theoretical), 701.1904 (measured).
Example 4
Synthesis of Compound III-2
Dissolving compound III-3 in DMF, heating to 50 deg.C, adding hydrazine acetate, stirring for 20 min, cooling, adding ethyl acetate, washing with saturated saline solution, drying with anhydrous sodium sulfate, filtering, and concentrating. Adding dichloromethane, cooling to-10 ℃, dropwise adding trichloroacetonitrile and DBU, slowly raising the temperature to room temperature after dropwise adding, and stirring for 2 hours. Concentrating, separating by column chromatography to obtain compound III-2, yellow liquid. High resolution mass spectrometry data: [ M + Na ]]+802.0906 (theoretical), 802.0906 (measured).
Example 5
Synthesis of Compound III-1
The compound III-2 and toluene are steamed together, and then anhydrous dichloromethane is added,Stirring the molecular sieve and 2-chloroethoxy-2-ethoxy diethanol at room temperature for 1.5 hours, cooling to-50 ℃, adding boron trifluoride diethyl etherate, and heating to 2 ℃ within 2 hours. Washed with saturated sodium bicarbonate solution and brine, dried over anhydrous sodium sulfate, filtered, and concentrated. Adding anhydrous DMF and NaN3And TBAI, stirred at 87 ℃ for 17 hours. Concentrating, separating by column chromatography to obtain compound III-1 as colorless liquid. High resolution mass spectrometry data: [ M + Na ]]+816.2586 (theoretical), 816.2589 (measured).
Example 6
Synthesis of mannobiose ligand III
Hydrolyzing the compound III-1 under alkaline condition to prepare the mannobiose ligand III as colorless liquid. Nuclear magnetic data (1H NMR,400MHz, internal standard TMS, solvent CDCl3) The following were used: delta ppm 5.03(d,1H, J)1a,2a1.7Hz,H-1a),4.94(d,1H,J1b,2b 1.7Hz,H-1b),3.98(dd,1H,J2b,3b 3.4Hz,J1b,2b 1.7Hz,H-2b),3.90(dd,1H,J2a,3a3.4Hz,J1a,2a 1.7Hz,H-2a),3.82-3.76(m,5H,H-3a,H-3b,H-6,H-6’,CH2O),3.70-3.53(m,15H,C-4a,C-4b,C-5a,C-5b,C-6,C-6,CH2O),3.42(t,2H,J 4.87Hz,CH2-N); high resolution mass spectrometry data: [ M + Na ]]+522.2352 (theoretical), 522.1905 (measured).
Example 7
Synthesis of alkynylamine IV-1(n ═ 2)
Mixing diglycolamine 10mL, tetrahydrofuran 100mL and H2O100mL, 24.0g of di-tert-butyl dicarbonate and 31.8g of sodium carbonate were added thereto, and after stirring at room temperature for 24 hours, the pH was adjusted to about 5 with 2mol/L hydrochloric acid, followed by extraction with ethyl acetate, drying over anhydrous sodium sulfate, filtration, rotary evaporation, and dissolution in 30mL of tetrahydrofuran. And (3) adding 3.93g NaH into the mixed solution in an ice bath, stirring the mixed solution for 10 minutes, adding 4.48mL of bromopropyne, stirring the mixed solution for 4 hours at room temperature, adjusting the pH to be about 6 to 7 by using 2M hydrochloric acid, extracting an aqueous layer by using ethyl acetate, drying the aqueous layer by using anhydrous sodium sulfate, performing rotary evaporation, and performing column chromatography separation to prepare the alkynylamine IV-1 as a light yellow liquid. Mass spectrometry data: [ M + H ]]+144.10 (theoretical), 144.12 (measured).
Example 8
Synthesis of Boc protected aspartic acid IV-2
2g of aspartic acid, 10mL of dioxane and 30mLH2And mixing, adding 30mL of sodium hydroxide (1M) while stirring until the solution is clear, cooling in an ice bath, dropwise adding 10mL of dioxane solution of di-tert-butyl dicarbonate (3.6g), and stirring at room temperature overnight after dropwise adding. Rotary evaporation, addition of 20mL ethyl acetate, acidification with HCl (3M) to pH 2, drying over anhydrous sodium sulfate, filtration, rotary evaporation, column chromatography separation to afford Boc protected aspartic acid IV-2. Mass spectrometry data: [ M + H ]]+234.10 (theoretical), 234.11 (measured).
Example 9
Synthesis of Boc-protected alkynylamide IV-3(n ═ 2)
4.16g of compound IV-2, 11.03g of DCC and 30mL of dichloromethane are mixed, stirred and reacted for 1 hour at 0 ℃, 5.11g of alkynylamine IV-1 and a catalytic amount of DMAP are added, the temperature is slowly raised to room temperature, the mixture is stirred overnight, filtered, rotary-evaporated and separated by column chromatography, and Boc protected alkynylamide IV-3 is prepared as a yellow viscous liquid. Mass spectrometry data: [ M + H ]]+484.27 (theoretical), 484.26 (measured).
Example 10
Synthesis of alkynylamide IV-4(n ═ 2)
To a solution of compound IV-3(0.5g) in dichloromethane (10mL) at 0 ℃ was added 0.5mL of trifluoroacetic acid, stirred at 0 ℃ for 2.5 hours, rotary evaporated, and dissolved in 10mL of methanol. Cooling to 5 ℃, adding 0.03g of potassium carbonate, stirring for 30 minutes, extracting with ethyl acetate, drying with anhydrous sodium sulfate, performing rotary evaporation, and performing column chromatography separation to prepare the alkynylamide IV-4 as a light yellow viscous liquid. Mass spectrometry data: [ M + H ]]+384.21 (theoretical), 384.24 (measured).
Example 11
Synthesis of Dithiobis-mannobiose ligand II (n ═ 2)
Mixing disulfide ligand IV (0.38g, 1mmol) and mannobiose ligand III (1.0g, 2mmol) in methanol, adding TBTA (0.042g, 0.19mmol) and CuSO4·5H2O (0.028g, 0.11mmol) and sodium ascorbate (0.08g, 0.41mmol) are stirred at room temperature in the dark, and subjected to rotary evaporation and column chromatography separation to prepare the dithiobis-mannobiose ligand II. The results of high resolution mass spectrometry (FIG. 1) show: [ M + Na + K ]]2+815.7968 (theoretical), 815.8078 (measured).
Example 12
Synthesis of bis-mannobiose gold nanoprobe I (n ═ 2)
2mL of gold nanoparticles (91mM) in PBS was concentrated to 200. mu.L, and bis-sulfur-bis-mannobiose ligand II (0.3g, 0.36mol) and TCEP (0.124g, 0.432mol) were added thereto, followed by stirring overnight at room temperature in the dark. Concentrating, washing with water, preparing dithiobis-mannobiose-gold nanoprobe I, and characterizing by ultraviolet visible absorption spectrum (figure 2) and dynamic light scattering (figure 3), wherein lambda ismaxAt 530nm, the average particle size was 14.62 nm.
Example 13
Fluorescence quenching experiment
According to the experimental scheme shown in Table 1, the fluorescence spectrum of the bis-mannose-gold nanoprobe I + DC-SIGN/R and the fluorescence spectrum of the DC-SIGN/R (the excitation wavelength is 597nm) at different concentrations are respectively measured, and the fluorescence quenching efficiency QE% is calculated according to the formula (X-Y)/X (X, Y is the spectral peak area of the DC-SIGN/R, the sugar nanoprobe + DC-SIGN/R respectively). Using a Hill equation to fit and Origin software to draw a binding curve to obtain the binding affinity Kd. The results show that: the bonding force of the bis-mannose-gold nanoprobe I and the DC-SIGN is strong, the fluorescent quenching phenomenon is obvious after the two are mixed, and Kd5.74 (fig. 4); and binding to DC-SIGNRSlightly weak force, Kd55.30 (fig. 5). The buffer solutions used in the experiments were: NaCl (100mM), HEPES (20mM), CaCl2(10mM), containing 1mg/mL BSA solution.
TABLE 1 fluorescence quenching Experimental protocol
Claims (4)
2. The method for preparing the dithiobis-mannobiose-gold nanoprobe of claim 1, which is characterized by comprising the following steps:
dissolving 1 mole of gold nanoparticles, 1-2000 moles of bis-sulfur bis-mannobiose ligand II and 1-2500 moles of tris (2-carboxyethyl) phosphine in ultrapure water, stirring at room temperature in a dark place for 12-24 hours, concentrating, washing with water, and preparing a bis-sulfur bis-mannobiose-gold nanoprobe I, wherein the reaction formula is as follows:
wherein n is 1-10.
3. The method for preparing the bis-sulfur bis-mannobiose-gold nanoprobe according to claim 2, wherein the bis-sulfur bis-mannobiose ligand II is prepared by click chemistry from a mannobiose ligand III, a bis-sulfur ligand IV, tert-butyl trichloroacetimidate, copper sulfate pentahydrate and sodium ascorbate, and has the reaction formula:
wherein: n is 1-10;
the molar ratio of the disulfide ligand IV to the mannobiose ligand III to the tert-butyl trichloroacetimidate to the copper sulfate pentahydrate to the sodium ascorbate is 1: 2-3: 0.1-0.3: 0.05-0.2: 0.1-1, using methanol or ethanol as a solvent, stirring at room temperature in a dark place, and separating and purifying a product by column chromatography.
4. The use of the bis-sulfur bis-mannobiose-gold nanoprobe of claim 1 in the preparation of a virus receptor DC-SIGN/R detection reagent.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010787460.9A CN111777629B (en) | 2020-08-07 | 2020-08-07 | Dithiobis-mannobiose-gold nanoprobe, preparation method and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010787460.9A CN111777629B (en) | 2020-08-07 | 2020-08-07 | Dithiobis-mannobiose-gold nanoprobe, preparation method and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111777629A CN111777629A (en) | 2020-10-16 |
CN111777629B true CN111777629B (en) | 2022-03-29 |
Family
ID=72766028
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010787460.9A Active CN111777629B (en) | 2020-08-07 | 2020-08-07 | Dithiobis-mannobiose-gold nanoprobe, preparation method and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111777629B (en) |
-
2020
- 2020-08-07 CN CN202010787460.9A patent/CN111777629B/en active Active
Non-Patent Citations (1)
Title |
---|
Probing Multivalent Lectin-Carbohydrate Binding via Multifunctional Glycan-Gold Nanoparticles: Implications for Blocking Virus Infection;Darshita Budhadev等;《ChemRxiv》;20200629;全文 * |
Also Published As
Publication number | Publication date |
---|---|
CN111777629A (en) | 2020-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111777629B (en) | Dithiobis-mannobiose-gold nanoprobe, preparation method and application | |
CN106083993B (en) | Parents' polypeptide amine dendrimer and preparation method thereof | |
US20080194801A1 (en) | Robust multidentate ligands for diagnosis and anti-viral drugs for influenza and related viruses | |
CN110437283B (en) | Potassium ion fluorescent probe and preparation method and application thereof | |
CN115073435B (en) | Near infrared fluorescent probe for detecting hydrogen sulfide and preparation method thereof | |
CN113527364B (en) | Mn (II) complex multi-photon absorption material and preparation method and application thereof | |
CN101531683B (en) | Bipyridine ruthenium/osmium ECL marker with phenothiazine power supplying groups in molecules | |
WO2010027108A1 (en) | Fluorescent sugar derivative compound and sensor using same | |
CN114437053A (en) | Nano probe and application thereof in detecting superoxide anion in Golgi apparatus | |
JP3746181B2 (en) | Phenyldiazirine compounds and photoaffinity labeling reagents | |
CN118344419A (en) | Disulfide functionalized disaccharide gold nanoprobe, preparation method and application | |
CN109929003B (en) | Tetraphenylethylene compound containing sialic acid glycosyl unit, preparation method and application | |
CN116574081B (en) | Chlorogenic acid-Huang Qinsu conjugate and preparation method and application thereof | |
KR100670948B1 (en) | A bundle of carbohydrates covalently bonded to single molecule of cucurbituril derivative | |
KR101322615B1 (en) | Thiol-targeting chemodosimetric fluorescent probe, method for preparing the same, and method for bioimaging of thiol using the same | |
CN110563795A (en) | Preparation method and application of diosgenin derivative containing 1,3,4 oxadiazole or 1,3,4 thiadiazole fragment | |
CN114853743B (en) | Cytosine-based cyanine probe and preparation method and application thereof | |
CN114736150B (en) | off-DNA and on-DNA synthesis method of arylselenoindole compound | |
JPH05255253A (en) | 2-aminopyridine derivative, production thereof and fluorescent marking agent | |
CN110305099B (en) | Preparation and application of nebivolol-based Smo inhibitor | |
WO2003016423A1 (en) | Hydrogelation agents | |
CN1803822A (en) | Method for preparing adenosine | |
Leikauf et al. | A new colorimetric protecting group allowing deprotection under neutral conditions | |
CN108148152B (en) | Zanamivir polymaleic anhydride conjugate and synthesis method thereof | |
CN108727435B (en) | 12-fluorobenzoimidazole-1, 8-naphthalimide-platinum complex and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |